PharmaVoice 19. Feb. 2026 Will vaccine regulatory uncertainty chill innovation? Pharma execs sound off.
PharmaVoice 17. Feb. 2026 More drugmakers are turning to cancer combos. Will it help patients live longer?
PharmaVoice 12. Feb. 2026 Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift
PharmaVoice 11. Feb. 2026 A protein model designed for space could expand pharma’s definition of ‘druggability’
PharmaVoice 3. Feb. 2026 Investors crave safer, market-ready biotech bets, widening the early-stage funding gap